Showing 10,781 - 10,800 results of 44,452 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (mean decrease)) ))', query time: 0.85s Refine Results
  1. 10781
  2. 10782

    Summary of calculations for regression estimates. by Jason Fletcher (816591)

    Published 2024
    “…Indeed, typical results from sibling analysis show large (>50%) attenuations in the associations between polygenic scores and phenotypes compared to non-sibling analysis, consistent with researchers’ expectations about bias reduction. …”
  3. 10783
  4. 10784
  5. 10785

    Evaluation of the temperature of posterior lower limbs skin during the whole body vibration measured by infrared thermography: Cross-sectional study analysis using linear mixed eff... by Eloá Moreira-Marconi (6453503)

    Published 2019
    “…</p><p>Conclusions</p><p>The acute exposure of 60-second mechanical vibration has effect on the behavior of Tsk of the posterior region of the lower limbs, which is likely to be associated with a decrease on the blood flow due to WBVE. It is speculated that during WBVE a greater supply of blood is required where the body responds by shunting blood flow from the skin to working muscle in the first seconds of exercise. …”
  6. 10786
  7. 10787

    REG-O3 chimeric peptide combining growth hormone and somatostatin sequences improves joint function and prevents cartilage degradation in rat model of traumatic knee osteoarthritis by Rodrick Montjean (400649)

    Published 2020
    “…The effect of REG-O3, solubilized in a liposomal solution and injected at either 5, 25 or 50 μg/50 μL, was compared to liposomal (LIP), dexamethasone and hyaluronic acid (HA) solutions. …”
  8. 10788
  9. 10789
  10. 10790

    Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis by Zhixia Li (2736331)

    Published 2016
    “…Dulaglutide, exenatide long-acting release (exe_lar), liraglutide and taspoglutide had significant lowering effect when compared with sitagliptin (HbA1c<7.0%) and insulin (HbA1c<6.5%). Finally, according to SUCRAs, placebo, thiazolidinediones and albiglutide had the best decrease effect on hypoglycemia; sulphanylureas, sitagliptin and insulin decrease the incidence of treatment discontinuation most; exe_lar and dulaglutide had the highest impact on glycemic level among 13 treatments.…”
  11. 10791
  12. 10792

    Effect of partial Glo-I inhibition by EP on LPS-induced production of TNF-α, collagen-I and α-SMA in HSC. by Marcus Hollenbach (376231)

    Published 2017
    “…Presence of LPS and treatment with low-level concentrations of MGO (indicating partial inhibition of Glo-I activity without complete enzyme inhibition) showed significant decrease of LPS-induced release of TNF-α (absence vs. presence of 10mM MGO: 371.8±22.7 vs. 60.9±11.2 pg/ml; p<0.001), collagen-I (10.0±0.3 vs. 1.8±0.5 ng/ml; p<0.001) and α-SMA (68.6±3.6 vs. 43.8±2.2 ng/ml; p<0.001) <b>(A2, B2, C2)</b>. …”
  13. 10793

    Effects of 20 μM 5-aza-dC Treatment on the 10q25 Neocentromere by Nicholas C Wong (14627)

    Published 2013
    “…Six CpG islets (28, 31, 69, 70, 71, and 101) showed an increase in DNA methylation upon the formation of the 10q25 neocentromere. However, following 5-aza-dC treatment, the methylation level of these CpG islets decreased significantly. …”
  14. 10794
  15. 10795

    LM11A-31's effect on cholinergic dystrophic neurites in cortex of mid-stage APP<sup>L/S</sup> mice. by Danielle A. Simmons (621167)

    Published 2014
    “…Scale bar in photomicrograph A = 50 µm. Quantitative analysis showed that LM11A-31 decreases the total area occupied by the clusters (<b><i>C</i></b>) by decreasing their number (<b><i>D</i></b>) but not the mean area per cluster (<b><i>E</i></b>). …”
  16. 10796
  17. 10797
  18. 10798

    Effects of COS on the expression of MCP-1 and iNOS mRNA in RGC-5 cells. by I-Mo Fang (470460)

    Published 2013
    “…<p>RGC-5 cells were stimulated with 0.5mM PQ and then treated with 50 μg/ml (low-dose) or 100 μg/ml (high-dose) COS for 12 hours. …”
  19. 10799
  20. 10800

    Sensitivity of U251 stable clones to GCV. by Elizabeth Wei-Chia Luo (11250668)

    Published 2021
    “…<p>U251, U251-pCMV-HSVtk, and U251-pGFAP-HSVtk cells were treated with 0, 1, 5, or10 μg/ml of GCV for 5 days. (A–D) Live-cell phase images of U251 parent cells displayed no cytotoxicity up to 10 μg/ml of GCV. …”